1School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, New South Wales, Australia
2Sydney Institute of Traditional Chinese Medicine, Haymarket, New South Wales, Australia
3NICM Health Research Institute, Western Sydney University, Westmead, New South Wales, Australia
4Department of Chinese Medicine, Endeavour College of Natural Health, Haymarket, New South Wales, Australia
©2025 Jaseng Medical Foundation
This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Acknowledgments
The authors express their gratitude to all the healthy participants who took part in this study. Access to the UTS Chinese Medicine Clinic is also much appreciated.
Author Contributions
Conceptualization: CZ. Methodology: CZ and XW. Formal investigation: CZ and XW. Data analysis: XW. Writing original draft: XW. Writing - review and editing: XW, CZ, CEDL, and SZ.
Conflicts of Interest
This study was based on a thesis chapter presented to University of Technology Sydney as a PhD thesis. The thesis was published in the Open Publications of UTS Scholars (https://opus.lib.uts.edu.au/).
Funding
This research was supported by an Australian Government Research Training Program Scholarship.
Ethical Statement
The Human Research Ethics Committee approval (no.: ETH18-2294; 09 November 2018) was granted prior to commencing the study, and before enrolment. All study participants provided written informed consent.
Intervention | N | Mean % PPT change | Median | SD | 95% CI | p (adjusted) |
---|---|---|---|---|---|---|
SI3m− | 31 | 16.1 | 15.2 | 19.5 | 14.0 to 18.3 | < 0.001 |
SI3m+ | 31 | 23.7 | 22.1 | 21.1 | 21.4 to 26.1 | < 0.001 |
SL | 31 | 0.2 | 0 | 12.2 | −1.1 to 1.6 | 0.3 |
Regional site | SI3m− (n = 31) | SI3m+ (n = 31) | SL (n = 31) | |||
---|---|---|---|---|---|---|
Acupoint | Mean | SD | Mean | SD | Mean | SD |
HT7R | 6.0* | 18.3 | 15.5** | 18.2 | −1.2 | 13.7 |
SI11R | 13.6** | 17.8 | 24.5** | 20.4 | 2.7 | 12.5 |
GB21R | 10.7** | 19.5 | 20.3** | 20.4 | 3.3 | 10.3 |
GV14 | 17.4** | 18.3 | 24.4** | 23.6 | 1.1 | 11.9 |
GB21L | 17.1** | 17.9 | 20.2** | 19.0 | 1.0 | 10.6 |
SI11L | 22.5** | 19.8 | 32.6** | 22.2 | 0.8 | 13.5 |
GV4 | 24.5** | 20.5 | 31.6** | 27.7 | 0.1 | 15.4 |
HT7L | 16.5** | 17.9 | 22.6** | 16.7 | −0.9 | 10.7 |
BL60L | 15.2** | 18.8 | 22.7** | 20.6 | 0.7 | 13.2 |
BL60R | 17.9** | 21.6 | 22.7** | 17.6 | 1.4 | 9.6 |
Sites | Intervention pair | ||
---|---|---|---|
SI3m− with SI3m+ | SI3m− with SL | SI3m+ with SL | |
HT7R |
p = 0.076 −19.7 to 0.8 |
p = 0.216 −2.9 to 17.5 |
p = 0.001* 6.5 to 26.9 |
SI11R |
p = 0.038* −21.3 to −0.5 |
p = 0.038* 0.5 to 21.3 |
p < 0.001* 11.4 to 32.2 |
GB21R |
p = 0.080 −20.0 to 0.9 |
p = 0.006* 3.5 to 24.5 |
p < 0.001* 13.1 to 34.0 |
GV14 |
p = 0.303 −18.3 to 4.2 |
p = 0.002* 5.0 to 27.5 |
p < 0.001* 12.0 to 34.5 |
GB21L |
p = 0.731 −13.0 to 6.7 |
p = 0.001* 6.3 to 26.0 |
p < 0.001* 9.4 to 29.1 |
SI11L |
p = 0.093 −21.5 to 1.3 |
p < 0.001* 10.3 to 33.1 |
p < 0.001* 20.4 to 43.2 |
GV4 |
p = 0.407 −20.3 to 6.1 |
p < 0.001* 11.2 to 37.6 |
p < 0.001* 18.3 to 44.7 |
HT7L |
p = 0.276 −15.4 to 3.3 |
p < 0.001* 8.1 to 26.8 |
p < 0.001* 14.2 to 32.9 |
BL60L |
p = 0.226 −18.3 to 3.3 |
p = 0.005* 3.7 to 25.2 |
p < 0.001* 11.2 to 32.7 |
BL60R |
p = 0.502 −15.2 to 5.4 |
p = 0.001* 6.1 to 26.7 |
p < 0.001* 11.0 to 31.6 |
Study period | |||||||||
---|---|---|---|---|---|---|---|---|---|
Enrolment | Allocation | Post-allocation | Close-out | ||||||
Time point | Pre-intervention | Day 1 | Day 8 | Day 15 | Day 22 | ||||
- Day 7 | 0 | Pre | Post | Pre | Post | Pre | Post | Follow up | |
Recruitment | |||||||||
Information sheets | × | ||||||||
Trial Entry Assessment | × | ||||||||
Enrollment | |||||||||
Trial Entry Assessment | × | ||||||||
Eligibility screen | × | ||||||||
Informed consent | × | ||||||||
Health Evaluation | × | ||||||||
Allocation | × | ||||||||
Interventions | |||||||||
SI3m+ |
| ||||||||
SI3m− |
| ||||||||
SL |
| ||||||||
Assessments: | |||||||||
PPT | × | × | × | × | × | × | |||
Reporting | |||||||||
Adverse reaction |
| ||||||||
Incident |
|
Characteristics | Frequency (N = 31) |
---|---|
Age (y) | |
Mean | 41.9 |
Median ± SD | 43 ± 14.0 |
Range | 19–66 |
Gender | |
Female | 16 |
Male | 15 |
Height (cm) | |
Mean | 167.36 |
Median ± SD | 166 ± 9.0 |
Range | 153–186 |
Weight (kg) | |
Mean | 65.81 |
Median ± SD | 61.7 ± 14.6 |
Range | 45–107 |
BMI (kg/m2) | |
Mean | 23.2 |
Median ± SD | 22.5 ± 3.8 |
Range | 17.6–32.0 |
Acupuncture experience | |
Naïve | 10 |
Had experience | 21 |
Intervention | N | Mean % PPT change | Median | SD | 95% CI | p (adjusted) |
---|---|---|---|---|---|---|
SI3m− | 31 | 16.1 | 15.2 | 19.5 | 14.0 to 18.3 | < 0.001 |
SI3m+ | 31 | 23.7 | 22.1 | 21.1 | 21.4 to 26.1 | < 0.001 |
SL | 31 | 0.2 | 0 | 12.2 | −1.1 to 1.6 | 0.3 |
Intervention | Pair | Difference | CI | p |
---|---|---|---|---|
SI3m− | SI3m+ | −7.6 | −10.9 to −4.2 | < 0.001 |
with | SL | 15.9 | 12.5 to 19.2 | < 0.001 |
SI3m+ | SI3m− | 7.6 | 4.2 to 10.9 | < 0.001 |
with | SL | 23.5 | 20.1 to 26.8 | < 0.001 |
SL | SI3m− | −15.9 | −19.2 to −12.5 | < 0.001 |
with | SI3m+ | −23.5 | −26.8 to −20.1 | < 0.001 |
Regional site | SI3m− (n = 31) | SI3m+ (n = 31) | SL (n = 31) | |||
---|---|---|---|---|---|---|
Acupoint | Mean | SD | Mean | SD | Mean | SD |
HT7R | 6.0 |
18.3 | 15.5 |
18.2 | −1.2 | 13.7 |
SI11R | 13.6 |
17.8 | 24.5 |
20.4 | 2.7 | 12.5 |
GB21R | 10.7 |
19.5 | 20.3 |
20.4 | 3.3 | 10.3 |
GV14 | 17.4 |
18.3 | 24.4 |
23.6 | 1.1 | 11.9 |
GB21L | 17.1 |
17.9 | 20.2 |
19.0 | 1.0 | 10.6 |
SI11L | 22.5 |
19.8 | 32.6 |
22.2 | 0.8 | 13.5 |
GV4 | 24.5 |
20.5 | 31.6 |
27.7 | 0.1 | 15.4 |
HT7L | 16.5 |
17.9 | 22.6 |
16.7 | −0.9 | 10.7 |
BL60L | 15.2 |
18.8 | 22.7 |
20.6 | 0.7 | 13.2 |
BL60R | 17.9 |
21.6 | 22.7 |
17.6 | 1.4 | 9.6 |
Sites | Intervention pair | ||
---|---|---|---|
SI3m− with SI3m+ | SI3m− with SL | SI3m+ with SL | |
HT7R | p = 0.076 −19.7 to 0.8 |
p = 0.216 −2.9 to 17.5 |
p = 0.001 6.5 to 26.9 |
SI11R | p = 0.038 −21.3 to −0.5 |
p = 0.038 0.5 to 21.3 |
p < 0.001 11.4 to 32.2 |
GB21R | p = 0.080 −20.0 to 0.9 |
p = 0.006 3.5 to 24.5 |
p < 0.001 13.1 to 34.0 |
GV14 | p = 0.303 −18.3 to 4.2 |
p = 0.002 5.0 to 27.5 |
p < 0.001 12.0 to 34.5 |
GB21L | p = 0.731 −13.0 to 6.7 |
p = 0.001 6.3 to 26.0 |
p < 0.001 9.4 to 29.1 |
SI11L | p = 0.093 −21.5 to 1.3 |
p < 0.001 10.3 to 33.1 |
p < 0.001 20.4 to 43.2 |
GV4 | p = 0.407 −20.3 to 6.1 |
p < 0.001 11.2 to 37.6 |
p < 0.001 18.3 to 44.7 |
HT7L | p = 0.276 −15.4 to 3.3 |
p < 0.001 8.1 to 26.8 |
p < 0.001 14.2 to 32.9 |
BL60L | p = 0.226 −18.3 to 3.3 |
p = 0.005 3.7 to 25.2 |
p < 0.001 11.2 to 32.7 |
BL60R | p = 0.502 −15.2 to 5.4 |
p = 0.001 6.1 to 26.7 |
p < 0.001 11.0 to 31.6 |
Comparisons are shown with 95% confidence intervals (CI) and adjusted
Comparisons found statistically significant (95% confidence intervals and adjusted